SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-014382
Filing Date
2022-05-13
Accepted
2022-05-13 17:12:21
Documents
23
Period of Report
2022-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ck00018242493-20220513.htm   iXBRL 8-K 44969
2 EX-4.1 ex41_ladenburg-vlonxrdmay2.htm EX-4.1 132102
3 EX-5.1 ex51_opinion-vallonxsecuri.htm EX-5.1 12839
4 EX-10.1 ex101_paavlon-ladenburgmay.htm EX-10.1 99339
5 EX-10.2 ex102_vlonspa6.htm EX-10.2 282284
6 EX-99.1 ex991_vlon-pressreleasexre.htm EX-99.1 13866
10 ck00018242493-20220513_g1.jpg GRAPHIC 16879
11 ck00018242493-20220513_g2.jpg GRAPHIC 1656
12 ck00018242493-20220513_g3.jpg GRAPHIC 95792
13 image_0a.jpg GRAPHIC 43572
14 thfooter.jpg GRAPHIC 53854
15 thheader.jpg GRAPHIC 51344
  Complete submission text file 0001628280-22-014382.txt   1333416

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck00018242493-20220513.xsd EX-101.SCH 1941
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck00018242493-20220513_lab.xml EX-101.LAB 25848
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck00018242493-20220513_pre.xml EX-101.PRE 13598
17 EXTRACTED XBRL INSTANCE DOCUMENT ck00018242493-20220513_htm.xml XML 11523
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 22923965
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences